Benzinga | Jun 30, 2021 07:09AM EDT

NuVasive Receives CE Mark Approval For Pulse Platform And Starts Global Clinical Evaluations

NuVasive, Inc. (NASDAQ:NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that the Pulse(r) platform received CE Mark approval for its latest design update and clinical evaluations are underway in multiple countries throughout Europe.